The mechanisms and functions of IL-1β in intervertebral disc degeneration
Experimental Gerontology · 2023-06 · 177 · 112181
DOI: 10.1016/j.exger.2023.112181 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Experimental Gerontology, 2023-06. Verfasst von Hongtao Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spinal Surgery, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Sichuan, China. Hauptthemen laut MEDLINE: Intervertebral Disc Degeneration. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sichuan Province Science and Technology Support Program, Department of Science and Technology of Sichuan Province.
Abstract (Originalsprache)
Intervertebral disc degeneration (IDD) is the leading cause of low back pain (LBP) and disability in the elderly, imposing significant public health and economic burden worldwide. Meanwhile, the pathological mechanisms of IDD remain complicated, and treatment strategy to reverse IDD is primarily due to the unclear specific mechanisms of IDD and the lack of particular effective targets. Interleukin-1β (IL-1β), one of the most important members of the IL-1 family, can induce solid pro-inflammatory activity by stimulating the secretion of various pro-inflammatory mediators and is considered the key to IDD mediator. However, in recent years, IL-1β is considered to be able to regulate IVD cell death in many ways, such as apoptosis, pyroptosis, ferroptosis, and so on. At the same time, numerous studies on IL-1β inhibitors suggest that inhibition of IL-1β may be a promising biological therapy for IDD. Many IL-1β inhibitors have been investigated through various pathogenic biological mechanisms, including inhibiting inflammatory processes, regulating ECM degradation, and more. Therefore, anti-IL-1β therapy may have the effect of alleviating disc degeneration. This article mainly reviews the mechanisms and functions of IL-1β in IDD and investigates advances in IL-1β inhibition as a promising biotherapeutic approach for disc degeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Spinal Surgery, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Sichuan, China.
- Department of Spinal Surgery, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Sichuan, China. Electronic address: huige10141118@163.com.
- Department of Spinal Surgery, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Sichuan, China. Electronic address: jht187@163.com.
Förderung
- Sichuan Province Science and Technology Support Program
- Department of Science and Technology of Sichuan Province
Zitieren
APA
Li, H., Wang, X., Pan, H., Xiao, C., Wang, C., Guo, S., Long, L., Shi, H., Chen, H., & Li, S. (2023). The mechanisms and functions of IL-1β in intervertebral disc degeneration. Experimental Gerontology, 177, 112181. https://doi.org/10.1016/j.exger.2023.112181
Vancouver
Li H, Wang X, Pan H, Xiao C, Wang C, Guo S, et al. The mechanisms and functions of IL-1β in intervertebral disc degeneration. Experimental Gerontology. 2023;177:112181. doi:10.1016/j.exger.2023.112181
BibTeX
@article{Li2023,
author = {Li, Hongtao and Wang, Xiaoqiang and Pan, Hongyu and Xiao, Changming and Wang, Chenglong and Guo, Sheng and Long, Longhai and Shi, Houyin and Chen, Hui and Li, Sen},
title = {The mechanisms and functions of IL-1β in intervertebral disc degeneration},
journal = {Experimental Gerontology},
year = {2023},
volume = {177},
pages = {112181},
doi = {10.1016/j.exger.2023.112181}
}
EUVIMED